#Cancer Registry Software Market size

[janetushar1]

Cancer Registry Software Market to Hit $108.38 Billion by 2032

What's Trending in Cancer Registry Software Market?

- Keep Yourself Up-To-Date With The Latest Market Trends.

The global Cancer Registry Software Market was valued at USD 56.42 Billion in 2024 and it is estimated to garner USD 108.38 Billion by 2032 with a registered CAGR of 8.5% during the forecast period 2024 to 2032.

Firstly, the Market report for Cancer Registry Software Market describes the current state of the companies and recommends where it is likely to go next. The report shows the production, revenue, price, market share, and growth rate of each type, mainly divided into Product Types and Product Applications etc.

Additionally, this market report focuses on offering key business measures such as real market moves, market size, qualities, and freedoms, as well as forecast opportunities. This Cancer Registry Software Market report also offers distinctive insights into wealthy regions such as Europe, North America, the Middle East, Africa, and Latin America.

Get a Sample Copy of the Cancer Registry Software Market Report at: https://www.vantagemarketresearch.com/cancer-registry-software-market-1610/request-sample

Top Competitors:

Elekta (Sweden), Electronic Registry Systems Inc. (US), Onco Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), McKesson Corporation (US) and others.

This market report has all the information you need to start or grow your business in the industry. It also includes market drivers, restraints, competitiveness, and geographic estimates, as well as a price and emerging market structure. It is a complete description of a company's business model, benchmarks, consumer preferences, value proposition, and net profit. This comprehensive Cancer Registry Software Market study also sheds light on key techniques that help companies truly assess their customers' buying behavior.

It represents global economic trends between 2024 and 2032. With the help of this market research, top companies can easily make smarter financial decisions. This market analysis is an excellent technique to help companies implement new products. It also includes critical data on major industry topics, including market expansions and evolving market conditions.

This well-researched Cancer Registry Software Market report describes the negative impact COVID-19 is having on various companies and offers companies recommendations on how to recover from the damage suffered by the outbreak as well as the nationwide quarantine. The plan analyzes the company's expectations and priorities, as well as the delivery of all crucial data.

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/cancer-registry-software-market-1610/0

This report analyzes key market segments by type, application, and geography. The geographic analysis section covers key regions such as Europe, North America, the Middle East, Africa, and the Asia-Pacific region.

This Cancer Registry Software Market report not only provides valuable data but outlines key goals, pricing strategies, and approaches to help market participants' recommendations in this report will make accelerating economic growth easy. It offers some specific tips and business-related data to help new competitors in the market grow their businesses and diversify their product lines. Companies in the industry should choose tactics that include new product launches, mergers, and partnerships to survive in the competitive marketplace and strengthen their position.

Regional Analysis

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

The quantitative information in this Cancer Registry Software Market analysis helps predict future sales and market penetration. This type of information is based on statistics. The qualitative information provided here will greatly help the key players understand the buyer's opinion of your brand. Improving business goals becomes easy with the information provided in this report.

The industries can draw some conclusions about their original goals. In business. This Cancer Registry Software Market research helps you make assumptions about your competition, customers, and the market in order to make informed business decisions. Additionally, it forecasts the competition in the market for the estimated period of 2024-2032. Effective decision-making in companies leads to business growth and is made possible by this precise market study.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/cancer-registry-software-market-1610

Some of the Key Questions Answered in this Report:

Which are the five top players of the Cancer Registry Software Market?

How will the Cancer Registry Software Market change in the upcoming years?

Which product and application will take a share of the Cancer Registry Software Market?

What will be the CAGR and size of the Cancer Registry Software Market throughout the forecast period?

What are the drivers and restraints of the Cancer Registry Software Market?

Which regional market will show the highest growth?

What is the current industry size, what will the market size be in 2030 and what will the growth rate be?

Who are the major competitors and what is their strategy?

What are the challenges to grow in the industry?

What are the market opportunities and challenges faced by the key vendors?

What are the barriers to entry for new players in the Cancer Registry Software industry?

Check Out More Reports

Global Electric Scooter Market:  Report Forecast by 2032

Global Bakery Processing Equipment Market: Report Forecast by 2032

Global Wheat Powder Grass Market: Report Forecast by 2032

Global Digital Camera Market: Report Forecast by 2032

Global Semiconductor Chips For Automotive Market: Report Forecast by 2032

[healthdivine]

🎗️💻 Fighting cancer with data! Cancer registry tools are streamlining research, care & survival outcomes 🔍

[sacredcresttribe]

Oncology EMR Software Market Size, Share & Trends Analysis Report By Product ,By End-use, And Segment Forecasts (2024-2031)

Oncology EMR Software Market Overview and Estimation The Oncology EMR (Electronic Medical Records) Software Market Size is poised for steady expansion, driven by growing cancer incidence, the push for value-based care, and the digitization of clinical workflows in oncology centers. According to industry data, the market is expected to grow at a compound annual growth rate (CAGR) of 7.7% from 2024 through 2031, reflecting strong uptake of specialized EMR solutions that integrate treatment planning, chemotherapy ordering, and oncology-specific analytics.

Oncology EMR Software Latest News and Trends In recent months, several key trends have shaped the Oncology EMR landscape:

Artificial Intelligence & Machine Learning Integration Leading vendors are embedding AI-driven decision-support modules into their EMRs to assist oncologists with protocol selection, early adverse-event detection, and personalized treatment pathways.

Interoperability Accelerators The 21st Century Cures Act in the U.S. and similar initiatives in Europe and Asia have intensified focus on seamless data exchange. Oncology EMRs are increasingly adopting FHIR-based APIs to share patient summaries, radiation therapy plans, and pathology results across hospitals, labs, and registries.

Cloud-Native Deployments A shift from on-premises implementations toward cloud-hosted, subscription-based models is underway—driven by lower upfront costs, faster upgrades, and enhanced remote-access capabilities for multi-site cancer centers.

Tele-oncology Modules COVID-era telehealth uptake has extended to specialty care: vendors now bundle video-consultation, e-consent, and remote symptom-reporting features directly within oncology EMRs, reducing the friction of managing virtual visits.

Real-World Evidence (RWE) Collection Payers and life-science firms are collaborating to use de-identified EMR data for RWE studies. Oncology EMRs are being enhanced to capture structured patient-reported outcomes and longitudinal safety data to support post-market surveillance and value dossiers.

Get Free Sample Pdf : https://www.datamintelligence.com/download-sample/oncology-emr-software-market

Oncology EMR Software Market Segmentation

The Oncology EMR market can be described across multiple dimensions, each demonstrating unique adoption dynamics:

By Component: Solutions (software licenses and perpetual-license packages) constitute the bulk of spending, as oncology centers prefer comprehensive suites that encompass treatment ordering, protocol management, and outcome tracking. Services—primarily customization, integration, and training—account for a significant share of revenue, especially among large academic cancer institutes requiring complex interfacing with laboratory, radiology, and pharmacy systems.

By Deployment Type: Historically, on-premises deployments led the market; however, recent migration trends show cloud-based oncology EMRs capturing nearly two-fifths of new deals by revenue share. Smaller hospitals and outpatient clinics favor cloud subscriptions for lower capital expenditure and predictable operating costs, while top-tier cancer centers continue to invest in on-prem deployments for tighter control over data sovereignty and advanced customization.

By End User: Comprehensive Cancer Centers represent the largest end-user segment, given their high patient volumes and the need for integrated care pathways. Hospitals with designated oncology wings follow closely, leveraging EMRs to coordinate multidisciplinary tumor-board discussions. Specialty outpatient clinics and physician practices collectively make up the remaining slice, adopting lightweight, focused solutions for chemotherapy ordering and patient scheduling.

By Functionality: Core modules—patient demographics, clinical documentation, and order entry—comprise the foundational spend. Advanced functionalities such as chemotherapy regimen libraries, radiation therapy interfacing, and billing-code mapping are driving incremental growth, together representing more than half of total annual license revenues.

Oncology EMR Software Regional Analysis: USA & Japan

United States: The U.S. commands the largest slice—approximately 40% of global Oncology EMR revenues—propelled by a mature healthcare IT infrastructure and robust reimbursement frameworks. The 21st Century Cures Act’s information-blocking rules have incentivized providers to adopt interoperable, certified EMR systems, while Medicare’s Oncology Care Model encourages tight integration between EMR data and value-based payment programs. The U.S. market is projected to grow at a CAGR slightly above the global average, fueled by consolidation among health systems and expansion of outpatient oncology networks.

Japan: Japan represents roughly 12–15% of global Oncology EMR spend, with steady annual growth. Government initiatives such as the “Society 5.0” healthcare vision and the Ministry of Health, Labour and Welfare’s push for digital hospital adoption have accelerated EMR deployments. However, slower legacy-system turnover and stringent data-localization policies temper cloud-migration rates. Local players often partner with global vendors to align with Japan’s unique clinical workflows and language requirements.

Key Highlights from Recent Reports

Oncology EMR solutions with integrated clinical-trial matching capabilities are seeing over 20% higher adoption rates at academic cancer centers.

Cloud-hosted oncology EMRs are reducing total cost of ownership by up to 25%, largely through automated updates and shared-service support models.

Interoperability accelerators such as SMART on FHIR apps are projected to triple in number by 2026, enabling rapid third-party innovation within oncology workflows.

Oncology EMR Software Key Players & Competitive Landscape:

The market is moderately consolidated, with the top five vendors holding a combined share of over 60%. Recent M&A and research highlights include:

Epic Systems – Dominant in large health systems; piloting AI-driven regimen optimization tools.

Oracle Cerner – Following the Cerner acquisition, expanding cloud-native oncology modules.

Allscripts – Partnering with life-sciences firms to integrate RWE-capture features.

GE Healthcare – Leveraging its imaging-informatics heritage to offer unified EMR-PACS-RT workflows.

athenahealth – Gaining traction among specialty clinics with its flexible, subscription-based oncology package.

Additionally, smaller niche vendors such as Aria (Oncology Information System by Varian) and Elekta iO EMR continue to innovate around radiation-oncology integrations and research-data export. 

Conclusion

The Oncology EMR Software Market is on a solid growth trajectory, underpinned by a projected 7.7% CAGR through 2031. As precision oncology, real-world evidence demands, and regulatory imperatives converge, providers will increasingly seek comprehensive, interoperable EMR platforms tailored to the complexities of cancer care. The transition toward cloud-native deployments and AI-enabled decision support will accelerate operational efficiencies, while regional dynamics—particularly in the U.S. and Japan—will shape adoption paths. Overall, the market is set to mature from a basic digital-record offering into a sophisticated, intelligence-driven platform central to the future of oncology treatment delivery.

[researchlog123]

Cancer Registry Software Market

Cancer Registry Software Market Size, Scope & Trend 2031

[marketreport22]

The “ Cancer Registry Software Market ” report provides a detailed analysis of global market size, regional and country-level market size, segmentation, market growth, market share, and competitive Landscape.

[medicaldevicetech]

Cancer Registry Software Market Overview, Industry News, Development Opportunities & Challenges – 2018-2024

Market Highlights

The global Cancer Registry Software Market held a market value of USD 56.4 million in 2019 and is projected to grow at a CAGR of 10.7% over the forecast period.  

Cancer registry software is a disease registry that is mainly used to establish and maintain a cancer incidence reporting system. It acts as an informational resource for the investigation of cancer and its causes. This type of registry software is important as cancer is among the leading causes of death worldwide and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial to help identify trends and ultimately improve care for patients that are fighting cancer.

However, privacy and data security-related concerns and reluctance to adopt advanced solutions may restrict the growth of the market during the forecast period.

Key Players

Some of the prominent players in the global cancer registry software market are Onco, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Elekta AB (PUB), C/Net Solutions, Electronic Registry Systems, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Ordinal Data Inc, Conduent Inc, IBM, Himagine Solutions Inc.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the innovative product development and increasing investment in research and development for innovation in the region.  

Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.

Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.

The Middle East & Africa has the least share of the global cancer registry software market.  Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

Intended Audience

Software companies

Contract research organizations

Academic and research institutes

Government associations

Segmentation

The global cancer registry software market has been segmented into type, deployment model, database type, functionality and end user.

By type, the market has been segmented into integrated software and standalone software.

Based on deployment model, the market has been segmented into cloud-based models and on-premise models.

On the basis of database type, the market has been segmented into commercial databases and public databases.

By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.

The market, by end user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.

Read More@ https://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852

Hottest Trends On Related Reports:

Vocal Biomarkers Market Research Report Forecast by 2023

Process Analytical Technology (PAT) Market Research Report- Global Forecast To 2022 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[kbvresearch]

The Global Cancer Registry Software Market size is expected to reach $90.8 Million by 2025, rising at a market growth of 10.33% CAGR during the forecast period

[sanpdr1994]

Patient Registry Software Market Research Report : Predictable To Exceed Market Income, Shares and Competitive Landscape 2032

The global patient registry software market is estimated at US$ 4.4 Billion while expanding at a CAGR of 8.8% from 2022 to 2032. The market is valued at US$ 1.9 Billion in 2022. The growth of the market can be attributed to the increasing adoption of EHRs in the healthcare sector. The implementation of various favorable government initiatives is expected to strengthen the market in the forecast period.

For instance, in 2016, the U.S introduced Cures Act, which aims to develop medical products and offer innovative technology in the medical sector. Also, the incorporation of AI into EHRs is anticipated to offer various opportunities for expansion. For instance, in October 2019, various scripts along with Northwell Health made an agreement to offer the next-generation electronic health record. The agreement aims to massive revenue generation, thereby, fuelling the market expansion in the coming time.

On the other hand, concerns associated with data privacy and security are expected to hinder the market growth in the forecast period. According to the Identity Theft Resource Center, the U.S recorded about 1.473 breaches in 2019, a rise of 17% against 2018. However, the emergence of cloud-based EHR is anticipated to offer significant opportunities to the market and act as a significant counter to the impeding cause, thereby, supporting the market expansion.

Key Takeaways from the Market Study

The global patient registry market is expected to garner US$ 1.9 Billion in 2022 Global market demand flourished at a 10.4% CAGR from 2015 to 2021 The commercial registry software segment to expand at 8.9% from 2022 to 2032 The US market size to garner US$ 1.5 Billion by 2032 Market in Brazil to value US$ 57 Million from 2022- to 2032 The CAGR of China is expected to be 10.5% from 2022 to 2032 The diabetes registry segment is projected to experience a CAGR of 9.3% from 2022 to 2032 “Increasing chronic diseases across the globe is anticipated to play an important role in driving the market. With the growing cases of cancer, cardiovascular, and diabetes, there has been a notable rise in demand for EHRs, which will impact the market positively in the coming time.”

Competition Analysis

Key players in the global patient registry software market include Dacima Software Inc., Evado eClinical Solutions, IQVIA, Global Vision Technologies Inc., and Invitae. Recent developments among key players are:

In June 2020, ArborMetrix Inc. (US) entered into a strategic partnership with The Society of Interventional Radiology (SIR). The initiative aims to offer the IR Quality Registry to enhance patient care by deploying analytics. In March 2021, ESO Solutions announced a strategic partnership with Virginia EMS Systems (US) to provide an EMS data repository and trauma registry across the state. In April 2021, IQVIA Holdings accomplished the remaining 40% of Q2 solutions from diagnostic information services providers Quest Diagnostics. In December 2020, ImageTrend, Inc. (US) disclosed the latest National Trauma Data Bank (NTDB) Data Dictionary that would be available in the Patient Registry from January 1, 2021. More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global patient registry software market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Type (Public Domain Registry Software, Commercial Registry Software), Disease Area (Diabetes Registry, Cardiovascular Registry, Cancer Registry, Rare Disease/Orphan Disease Registry, Other Chronic Disease Registry), End-User (Government, Commercial), & Regional (North America, Latin America, Europe, East Asia, South Asia & Oceania, and the Middle East & Africa).

[precedenceresearch]

Cancer Registry Software Market Global Sales Are Expected To Reach US$ 117.65 Billion by 2030

Cancer Registry Software Market Global Sales Are Expected To Reach US$ 117.65 Billion by 2030

The global cancer registry software market size is predicted to reach around US$ 117.65 billion by 2030, expanding at an annual CAGR of 9.1 percent, according to a 2022 study by Precedence Research, the Canada-based market Insight Company. The cancer registry software market has been forecast based on volume (kilo tons) and value (US$ Mn) from 2022 to 2030. The report analyses and forecasts the…

[market-research-future]

Palliative Care Market Statistics, Overview, Future Outlook and Share Analysis Till 2027

Market Highlights

Increasing incidence of diseases such as cancer, cardiovascular and infective disease are some of the drivers responsible for the market growth of global palliative care market. Other factors such as a growing number of palliative care centers worldwide, expanding aging demographics, increasing number of qualified physicians for palliative care are responsible for the rise in the global palliative market. The main object of palliative care is to enhance personal satisfaction for both the patient and family. This palliative care can be provided at any age and at any phase in a genuine ailment and can be furnished alongside remedial treatment.

But the high cost of treatment, less private or public funding to hospital facilities and other medical centers can be a major restraint for the growth of the global palliative care market.

Regional Analysis

North America is expected to take a major share in the global palliative care market because of good reimbursement and insurance coverage for palliative care services. Countries like Mexico in the Latin America region have a greater number of palliative care centers for children’s. The European market is expected to be the second-largest palliative care market. The market growth in this region can be because of government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of palliative care centers worldwide, extending application for homecare, increasing number of qualified physicians for palliative care center and expanding aging demographics are some of the factors responsible for the rise in global palliative care market. Asia-Pacific is expected to be the fastest-growing palliative care market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving the strong competition in the global palliative care market by producing a cost-effective treatment that is high in demand in local as well as in the global market. The market in the Middle East and Africa is expected to account for the smallest share in the global palliative care market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Access Report @ https://www.marketresearchfuture.com/reports/palliative-care-market-6336

Segmentation

The global palliative care market is segmented into type, applications, and end-users. On basis of types, the palliative market is further segmented into private residence care, hospice inpatient care, hospital inpatient care, nursing home, residential facility care and others. Based on application the palliative market is segmented into cancer, cardiac disease such a congestive heart failure, chronic obstructive pulmonary disease, kidney failure, Alzheimer, Parkinson’s, amyotrophic lateral sclerosis and others. On basis of end-user, the palliative market is segmented into hospitals, home care settings, palliative care center, long-term care centers, and rehabilitation centers.

Key Players

Some of the key players in the Global Palliative Care market are Vitas Healthcare Corporation, Skilled Healthcare Group Incorporated, Sunrise Senior Living LLC, Kindred Healthcare Incorporated, Gentiva Health Services Incorporated, Home Instead Senior Care Incorporated, Amedisys Incorporated, Genesis HealthCare Corporation.

Browse Related Reports at:

Telehealth Market Trends, Size, Growth, Share, Application and Analysis by 2024 | MRFR

Migraine Drugs Market by Type, Drug Class, Growth Analysis Till 2027 | MRFR

Patient Registry Software Market Size, Share, Type, Global Analysis, 2027 | MRFR